Prevention of Rapid Immune Elimination of Anti-lymphocytic Globulin in Transplant Patients

William T. Butler, Roger D. Rossen, Evan M. Hersh, Michael E. Debakey, Edward B. Diethrich, David K. Brooks, Denton A. Cooley, James J. Nora, Robert D. Leachman, Donald G. Rochelle, John J. Trentin, Kenneth P. Judd, Arthur C. Beall, Daniel E. Jenkins, Robert O. Morgen, Vernon Knight

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Prior treatment of human allograft recipients with aggregate-free normal horse immunoglobulin circumvents the problem of antibody formation in subsequent anti-lymphocytic globulin therapy.

Original languageEnglish (US)
Pages (from-to)856-860
Number of pages5
JournalNature
Volume224
Issue number5222
DOIs
StatePublished - Dec 1 1969

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Prevention of Rapid Immune Elimination of Anti-lymphocytic Globulin in Transplant Patients'. Together they form a unique fingerprint.

  • Cite this

    Butler, W. T., Rossen, R. D., Hersh, E. M., Debakey, M. E., Diethrich, E. B., Brooks, D. K., Cooley, D. A., Nora, J. J., Leachman, R. D., Rochelle, D. G., Trentin, J. J., Judd, K. P., Beall, A. C., Jenkins, D. E., Morgen, R. O., & Knight, V. (1969). Prevention of Rapid Immune Elimination of Anti-lymphocytic Globulin in Transplant Patients. Nature, 224(5222), 856-860. https://doi.org/10.1038/224856a0